Drug Guide

Generic Name

Aminosalicylic Acid

Brand Names Parasal, Paser

Classification

Therapeutic: Antitubercular agent

Pharmacological: Salicylate

FDA Approved Indications

  • Treatment of active tuberculosis, especially multi-drug resistant strains

Mechanism of Action

Inhibits bacterial folic acid synthesis by antagonizing para-aminobenzoic acid (PABA), leading to suppression of bacterial growth

Dosage and Administration

Adult: 250-500 mg orally 3 times daily, adjust based on response and tolerance

Pediatric: Dose based on weight, typically 25-50 mg/kg/day divided into 3 doses

Geriatric: Use with caution; start at lower doses due to potential renal impairment

Renal Impairment: Adjust dosage accordingly; monitor renal function closely

Hepatic Impairment: Use with caution; hepatic function monitoring recommended

Pharmacokinetics

Absorption: Well absorbed orally

Distribution: Distributed throughout body tissues; crosses cerebrospinal fluid

Metabolism: Primarily unchanged; minimal hepatic metabolism

Excretion: Excreted mainly via the kidneys

Half Life: Approximately 3-4 hours

Contraindications

  • Hypersensitivity to aminosalicylic acid or salicylates

Precautions

  • Renal impairment
  • Hepatic impairment
  • G6PD deficiency (risk of hemolytic anemia)
  • Use with caution in children and the elderly

Adverse Reactions - Common

  • Gastrointestinal upset (Common)
  • Nausea (Common)
  • Loss of appetite (Common)

Adverse Reactions - Serious

  • Hemolytic anemia (Rare)
  • Hypersensitivity reactions (e.g., rash, fever) (Rare)
  • Salicylate toxicity (e.g., tinnitus, vertigo) (Rare)

Drug-Drug Interactions

  • Other salicylates or NSAIDs (increased risk of bleeding and salicylate toxicity)
  • Methotrexate (increased toxicity)
  • Warfarin (increased bleeding risk)

Drug-Food Interactions

  • Alcohol (increased risk of gastrointestinal bleeding and salicylate toxicity)

Drug-Herb Interactions

  • Ginger, ginkgo (may increase bleeding risk)

Nursing Implications

Assessment: Monitor for signs of salicylate toxicity, renal function, and complete blood counts

Diagnoses:

  • Risk for bleeding
  • Risk for impaired renal function

Implementation: Administer with food to reduce gastrointestinal upset; monitor labs periodically

Evaluation: Therapeutic response (e.g., sputum conversion in TB), monitor for adverse reactions

Patient/Family Teaching

  • Take medication exactly as prescribed; do not overdose
  • Report signs of salicylate toxicity such as tinnitus, vertigo, or hearing loss
  • Use caution with alcohol and other NSAIDs
  • Maintain adequate hydration
  • Follow-up appointments for lab monitoring

Special Considerations

Black Box Warnings:

  • Use with caution due to potential for salicylate toxicity

Genetic Factors: G6PD deficiency increases risk of hemolytic anemia

Lab Test Interference: May cause false-positive urine glucose tests

Overdose Management

Signs/Symptoms: Tinnitus, vomiting, hyperventilation, dehydration, seizures

Treatment: Supportive care, gastric lavage if recent ingestion, activated charcoal, hemodialysis in severe cases

Storage and Handling

Storage: Store at room temperature, protected from moisture and light

Stability: Stable under proper storage conditions

This guide is for educational purposes only and is not intended for clinical use.